ATE255450T1 - Matrix für iontophorese - Google Patents

Matrix für iontophorese

Info

Publication number: ATE255450T1
Authority: AT; Austria
Prior art keywords: drug; humectant; weight; iontophoresis; proline
Prior art date: 1995-06-09

Application number

AT96108896T

Other languages

English (en)

Inventor

Yasuyuki Suzuki

Katsumi Iga

Yukihiro Matsumoto

Original Assignee

Hisamitsu Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-06-09

Filing date

1996-06-04

Publication date

2003-12-15

1996-06-04 Application filed by Hisamitsu Pharmaceutical Co filed Critical Hisamitsu Pharmaceutical Co

2003-12-15 Application granted granted Critical

2003-12-15 Publication of ATE255450T1 publication Critical patent/ATE255450T1/de

Links

239000011159 matrix material Substances 0.000 title abstract 2
239000003814 drug Substances 0.000 abstract 4
229940079593 drug Drugs 0.000 abstract 4
239000003906 humectant Substances 0.000 abstract 3
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 2
150000001413 amino acids Chemical class 0.000 abstract 2
150000005846 sugar alcohols Polymers 0.000 abstract 2
229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
230000002378 acidificating effect Effects 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
238000004090 dissolution Methods 0.000 abstract 1
235000011187 glycerol Nutrition 0.000 abstract 1
239000007788 liquid Substances 0.000 abstract 1
108090000765 processed proteins & peptides Proteins 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis

Landscapes

Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Radiology & Medical Imaging (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Steroid Compounds (AREA)

AT96108896T 1995-06-09 1996-06-04 Matrix für iontophorese ATE255450T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP14298395		1995-06-09
JP20190295		1995-08-08

Publications (1)

Publication Number	Publication Date
ATE255450T1 true ATE255450T1 (de)	2003-12-15

Family

ID=26474826

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT96108896T ATE255450T1 (de)	1995-06-09	1996-06-04	Matrix für iontophorese

Country Status (5)

Country	Link
US (2)	US5993848A (de)
EP (1)	EP0747092B1 (de)
AT (1)	ATE255450T1 (de)
CA (1)	CA2178445A1 (de)
DE (1)	DE69630918T2 (de)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0813887A3 (de) *	1996-06-20	1999-11-03	Hisamitsu Pharmaceutical Co. Inc.	Iontophoretische Vorrichtung
CA2208332A1 (en) *	1996-06-20	1997-12-20	Hisamitsu Pharmaceuticals Co., Inc.	Drug administration composition for iontophoresis
EP0922467A3 (de)	1997-12-12	2000-05-24	Takeda Chemical Industries, Ltd.	Iontophoretische Verabreichung von Medikamenten
JP4154017B2 (ja) *	1997-12-30	2008-09-24	久光製薬株式会社	イオントフォレーシス装置および薬物ユニット
JP4154016B2 (ja) *	1997-12-30	2008-09-24	久光製薬株式会社	イオントフォレーシス装置およびその組み立て方法
US6322550B2 (en)	1998-04-14	2001-11-27	Hisamitsu Pharmaceutical Co., Inc.	Method for transdermal administration of GP IIb/IIIa antagonist
JP4868679B2 (ja)	1999-10-14	2012-02-01	ポーラ化成工業株式会社	エレクトロポーレーション用の組成物
EP1222930B1 (de) *	1999-10-14	2006-11-02	Pola Chemical Industries Inc.	Zusammensetzungen für die elektroporation
US7498297B2 (en) *	2000-07-18	2009-03-03	Cornell Research Foundation	Medicinal uses of mu-opioid receptor agonists
US6801804B2 (en)	2002-05-03	2004-10-05	Aciont, Inc.	Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis
US7099713B2 (en)	2002-06-28	2006-08-29	Battelle Memorial Institute	Skin conduction and transport systems
EP1599216B9 (de) *	2003-02-04	2015-02-11	Cornell Research Foundation, Inc.	Verfahren zum verhindern eines übergangs der mitochondrienpermeabilität
PL2604286T3 (pl) *	2003-05-01	2015-03-31	Cornell Res Foundation Inc	Sposoby i kompleksy nośnikowe do transportu cząsteczek do komórek
CA3024434A1 (en)	2004-01-23	2005-08-11	Cornell Research Foundation, Inc.	Methods for reducing oxidative damage
JP4615929B2 (ja) *	2004-08-11	2011-01-19	久光製薬株式会社	イオントフォレーシス装置
DE102005024040A1 (de) *	2005-05-25	2006-12-14	Rovi Gmbh & Co. Kosmetische Rohstoffe Kg	Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin
US20080274166A1 (en) *	2005-06-10	2008-11-06	Transpharma Medical Ltd.	Patch for Transdermal Drug Delivery
CN104788540B (zh) *	2005-09-16	2019-10-18	科内尔研究基金会	用于减少cd36表达的方法
US8281675B2 (en) *	2007-10-17	2012-10-09	Syneron Medical Ltd	Dissolution rate verification
JP5508272B2 (ja)	2007-10-29	2014-05-28	トランスファーマメディカルリミテッド	垂直的なパッチ乾燥
EP2712620A1 (de)	2008-02-07	2014-04-02	Cornell University	Verfahren zur Vorbeugung oder Behandlung von Insulinresistenz
EP3741381B1 (de)	2008-02-26	2024-04-24	Cornell University	Peptide zur verwendung zur prävention oder behandlung von akutem nierenversagen
US20110223204A1 (en) *	2008-06-04	2011-09-15	Bradford J Duft	Treatment of pain with gap junction modulation compounds
US20100331265A1 (en) *	2009-03-20	2010-12-30	Tompkins Ronald G	Methods for the prevention and treatment of burn injuries and secondary complications
WO2011019809A1 (en) *	2009-08-12	2011-02-17	Cornell University	Methods for preventing or treating metabolic syndrome
ES2964555T3 (es)	2009-08-24	2024-04-08	Stealth Biotherapeutics Inc	Péptido para uso en la prevención o tratamiento de la degeneración macular
WO2011044044A1 (en) *	2009-10-05	2011-04-14	Cornell University	Methods for the prevention or treatment of heart failure
KR101825111B1 (ko)	2011-10-28	2018-03-14	인디언 인스티튜트 오브 테크놀로지 마드라스	압전 장치 및 그 제조 및 사용 방법
CA2868534A1 (en)	2012-03-27	2013-10-03	Coda Therapeutics, Inc.	Compositions and treatments based on cadherin modulation
JP2015520754A (ja)	2012-05-18	2015-07-23	オタゴイノベーションリミテッド	創傷治癒のための組合せ治療および組成物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4593053A (en) *	1984-12-07	1986-06-03	Medtronic, Inc.	Hydrophilic pressure sensitive biomedical adhesive composition
IE60941B1 (en) *	1986-07-10	1994-09-07	Elan Transdermal Ltd	Transdermal drug delivery device
US5250022A (en) *	1990-09-25	1993-10-05	Rutgers, The State University Of New Jersey	Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose
US5612347A (en) *	1988-03-28	1997-03-18	Janssen Pharmaceutica N.V.	Agents for preserving or restoring the soundness of the skin
CA2026885C (en) *	1989-02-06	1998-12-01	Keiichirou Okabe	Interface for iontophorese
JPH0532696A (ja) *	1990-09-28	1993-02-09	Takeda Chem Ind Ltd	副甲状腺ホルモン誘導体
US5158537A (en) *	1990-10-29	1992-10-27	Alza Corporation	Iontophoretic delivery device and method of hydrating same
AU3070892A (en) *	1991-11-12	1993-06-15	Nepera, Inc.	Adhesive hydrogels having extended use lives and process for the preparation of same
EP0552879B1 (de) *	1992-01-21	1998-08-19	Macrochem Corporation	Iontophoretische verbesserte Verabreichung von Medikamenten
DE69326461T2 (de) *	1992-06-11	2000-05-04	Theratech Inc., Salt Lake City	Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung
JPH0616535A (ja) *	1992-07-03	1994-01-25	Japan Tobacco Inc	イオントフォレーゼ用インターフェイス
JPH0616538A (ja) *	1992-07-03	1994-01-25	Japan Tobacco Inc	イオントフォレーゼのための薬物吸収用液組成物
ES2180546T3 (es) *	1992-07-23	2003-02-16	Hisamitsu Pharmaceutical Co	Composicion basica administrable percutaneamente y composicion de farmaco preparada a partir de ella.
EP0643981B1 (de) *	1993-09-22	2002-01-09	Hisamitsu Pharmaceutical Co., Inc.	Iontophoresematrix
US5472958A (en) *	1994-08-29	1995-12-05	Abbott Laboratories	2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function

1996
- 1996-06-04 AT AT96108896T patent/ATE255450T1/de not_active IP Right Cessation
- 1996-06-04 DE DE69630918T patent/DE69630918T2/de not_active Expired - Fee Related
- 1996-06-04 EP EP96108896A patent/EP0747092B1/de not_active Expired - Lifetime
- 1996-06-06 CA CA002178445A patent/CA2178445A1/en not_active Abandoned
- 1996-06-06 US US08/659,372 patent/US5993848A/en not_active Expired - Lifetime
1998
- 1998-08-21 US US09/137,744 patent/US6248349B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2178445A1 (en)	1996-12-10
DE69630918D1 (de)	2004-01-15
EP0747092A3 (de)	1998-04-08
EP0747092A2 (de)	1996-12-11
EP0747092B1 (de)	2003-12-03
US5993848A (en)	1999-11-30
US6248349B1 (en)	2001-06-19
DE69630918T2 (de)	2004-10-28

Legal Events

Date	Code	Title	Description
2004-06-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties

Publication	Publication Date	Title
ATE255450T1 (de)	2003-12-15	Matrix für iontophorese
ES2526707T3 (es)	2015-01-14	Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos
ATE196092T1 (de)	2000-09-15	Wachstumshormon-enthaltendeproteinformulierung
ATE204467T1 (de)	2001-09-15	Orale darreichungsform
CA2275890A1 (en)	1998-07-02	Stable liquid interferon formulations
FI882417A0 (fi)	1988-05-23	Transdermaalinen järjestelmä, sen valmistusmenetelmä ja käyttö
ATE442851T1 (de)	2009-10-15	1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
ATE305775T1 (de)	2005-10-15	Tulobuterol enthaltendes präparat für perkutane absorption
PT1017413E (pt)	2003-02-28	Formulacoes liquidas de interferao (beta)
CA2326662A1 (en)	1999-10-07	Therapeutic system which can be moisture-activated
ATE177942T1 (de)	1999-04-15	Lösung, die igf-1 enthält
EP0942743B1 (de)	2002-03-06	Topisches präparat zur abgabe eines peptidarzneimittels in lebewesen
ATE226832T1 (de)	2002-11-15	Mittel zur arzneistoffverabreichung durch iontophorese
OA12322A (en)	2006-05-12	Topical pharmaceutical preparation.
TH19245A (th)	1996-06-21	วิธีป้องกันการสลายของโปรตีนซี
CA2153787A1 (en)	1994-07-21	Solution containing igf-1
TH25313A (th)	1997-05-29	องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่